Public Company News

Live from ASCO 2023 | For the Third Consecutive Year, Ascentage Pharma Releases Promising Results of Alrizomadlin plus Pembrolizumab in Patients with Cutaneous Melanoma that Failed Immuno-Oncologic (IO) Therapies

SUZHOU, China, and ROCKVILLE, Md., June 5, 2023 /PRNewswire/ -- Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in developing novel therapies for cancer, chronic hepatitis B (CHB), and age-related diseases, announced today that it has released updated results from a Phase I...

2023-06-05 17:34 3151

EVE Energy Leadership Reveals World-Class Lithium Battery Innovations among the 2nd China International Battery Industry Cooperation Summit and CIBF 2023

* Mr. Samuel Sang, vice president of EVE Energy, delivered a keynote speech on the green and low-carbon manufacturing of lithium batteries and carbon reduction strategies at the 2nd China International Batter Industry Cooperation Summit * Dr. Zheng Zhong from the EVE Central Research Institut...

2023-06-05 16:00 5180

LG JOINS RE100 INITIATIVE, COMMITTING TO TRANSITION TO RENEWABLE ENERGY

Accelerating Journey Toward Carbon Neutrality, Company Continues Efforts to Realize ESG Vision of 'Better Life for All' SEOUL, South Korea, June 5, 2023 /PRNewswire/ -- LG Electronics (LG) has joined RE100 (Renewable Energy 100), a global initiative advocating for businesses to convert to 100 pe...

2023-06-05 16:00 3805

Lunit and Capio S:t Göran Hospital Collaborate to Address Radiologist Shortage with AI-Powered Mammography Analysis

- Lunit and Sweden's largest private hospital pioneering a new approach to combine radiologists' expertise with AI SEOUL, South Korea, June 5, 2023 /PRNewswire/ -- Lunit (KRX:328130.KQ), a leading global provider of AI-powered cancer diagnostic solutions, today announced the signing of a supply ...

2023-06-05 15:00 3082

Gencurix Announces Clinical Research Results At ASCO 2023 Demonstrating Outstanding Performance of GenesWell BCT, the Company's Breast Cancer Prognostic Test, Compared to Global Best-Selling Test, OncotypeDX

SEOUL, South Korea, June 4, 2023 /PRNewswire/ -- Gencurix (KOSDAQ #229000), a leading provider of cancer molecular diagnostics, announced the release of clinical research results directly comparing the accuracy of its breast cancer prognostic test, GenesW...

2023-06-05 14:37 3784

Rockwell Automation Features Executive Customers and Partners in New Thought Leadership Video Series

ROKStudios video program provides fresh perspectives on evolving technology trends and innovation driving better business outcomes in manufacturing, automation, and digital transformation BRUSSELS, June 5, 2023 /PRNewswire/ -- Rockwell Automation, Inc. (NYSE: ROK), the world's largest company de...

2023-06-05 14:00 3325

Chubb Establishes Aviation Hub in Singapore

Expansion brings Chubb products and services closer to Asian customers SINGAPORE, June 5, 2023 /PRNewswire/ -- Chubb today announced that it has set up an aviation hub inSingapore to develop further its general aviation and aerospace business.

2023-06-05 14:00 4779

American Society of Clinical Oncology confers highest honor upon Prof Hagop Kantarjian

SUZHOU, China and ROCKVILLE, Md., June 5, 2023 /PRNewswire/ -- Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in developing novel therapies for cancers, chronic hepatitis B (CHB), and age-related diseases, today announced that its Clinical Advisory Board member ProfHago...

2023-06-05 12:30 2685

Live from ASCO 2023 | Updated Data of Olverembatinib in SDH-Deficient GIST including a CBR of 93.8% Signals a Potential Clinical Breakthrough

SUZHOU, China and ROCKVILLE, Md., June 4, 2023 /PRNewswire/ -- Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in developing novel therapies for cancer, chronic hepatitis B (CHB), and age-related diseases, announced today that it has released updated clinical results of olv...

2023-06-05 11:51 2958

Harbour BioMed Announces First Patient Dosed in Phase I Study of First-in-Class Anti-B7H7 (HHLA2) Antibody HBM1020

* HBM1020 is a first-in-class therapeutic monoclonal antibody against B7H7/HHLA2 entering clinical development globally. * HBM1020 was generated from Harbour Mice® H2L2 transgenic mice platform. * HBM1020 has great potential to address huge unmet medical needs in patients with advanced malig...

2023-06-05 09:01 3096

Innovent Presents Phase 1b Clinical Data of IBI110 (Anti-LAG-3 Monoclonal Antibody) at the 2023 ASCO Annual Meeting

ROCKVILLE, Md. and SUZHOU, China, June 5, 2023 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncology, autoimmune, metabolic, ophthalmology and...

2023-06-05 08:00 6505

Innovent Updates Phase 1b Data of IBI939 (Anti-TIGIT Monoclonal Antibody) Combined with Sintilimab in Previously Untreated PD-L1-selected NSCLC at the 2023 ASCO Annual Meeting

ROCKVILLE, Md. and SUZHOU, China, June 4, 2023 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncology, autoimmune, metabolic, ophthalmology and...

2023-06-04 08:36 5729

Gracell Biotechnologies Presents Updated Data of Deep and Durable Responses for FasTCAR-T GC012F in Relapsed/Refractory Multiple Myeloma at 2023 ASCO Annual Meeting

Data on BCMA/CD19 dual-targeting FasTCAR-T GC012F showed 100% minimal residual disease (MRD) negativity and 82.8% MRD negative stringent complete response (sCR) in a predominantly high-risk relapsed/refractory multiple myeloma (RRMM) population Data on GC012F for treatment of B-NHL will be prese...

2023-06-04 02:15 4720

Innovent Announces the Second Breakthrough Therapy Designation by NMPA for Olverembatinib for the Treatment of Patients with SDH-Deficient GIST

ROCKVILLE, Md. and SUZHOU, China, June 3, 2023 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncology, metabolic, autoimmune, ophthalmology and...

2023-06-03 07:59 24119

Markor Opens Door to Dream Homes with Amazing Fusion of Technology and Art

GANZHOU, China, June 2, 2023 /PRNewswire/ -- Markor International Home Furnishings ("Markor") (SHE:600337), a leading Chinese producer of home furnishings, is currently participating in the 10th China Furniture Industry Expo (Ganzhou). As part of the commitment to exploring home aesthetics, the ...

2023-06-02 21:28 7267

Positive Shareholder Momentum Continues to Build In Support of Pelham Investment Partners LP's Campaign to Change Board of Directors of Nickel 28 Capital Corp., With Support From Shareholders and ISS

* Fellow shareholder Samara Capital Inc. holding voting control over approximately 7.4% of the issued and outstanding shares of Nickel 28 as of the record date, votesYELLOW Proxy "FOR" all Pelham's director nominees * ISS recognizes that "several credible governance and compensation issues ha...

2023-06-02 20:53 5191

MultiMetaVerse Announces Term Sheet Signed to Acquire Equity Stake in Taomee

SHANGHAI, June 2, 2023 /PRNewswire/ -- MultiMetaVerse Holdings Limited ("MMV" or the "Company"), an animation and entertainment company for young consumers in China, announced today that it has entered into a non-binding term sheet (the "Term Sheet") with Dongzheng Ruibo (Shanghai) Investment Cent...

2023-06-02 20:37 7595

Nisun International Regains Compliance with NASDAQ Minimum Bid Price Requirement

SHANGHAI, June 2, 2023 /PRNewswire/ -- Nisun International Enterprise Development Group Co., Ltd (Nasdaq: NISN) ("Nisun" or the "Company") announced today that it has received a Staff determination letter (the "Letter") from the Listing Qualifications Department of The Nasdaq Stock Market LLC ("N...

2023-06-02 20:30 7141

Trajan's Microsampling Devices Meet IVDR Compliance in Europe, UK

Mitra® and hemaPEN® receive regulatory certification as medical devices for remote blood sample collection in healthcare, clinical trials and home monitoring programs inEurope and United Kingdom. MELBOURNE, Australia, June 2, 2023 /PRNewswire/ -- Trajan Scientific and Medical, a leading provider...

2023-06-02 20:00 5576

Wondershare Launches Virbo - The Next Generation of AI Video Generator

VANCOUVER, BC, June 2, 2023 /PRNewswire/ -- Wondershare, a prominent software development company, is delighted to announce the launch of Virbo, an advanced AI-powered text-to-video creation tool. Virbo made its soft debut at the Dublin Tech Summit 2023, where it garnered considerable attention a...

2023-06-02 20:00 6377